DOW JONES27,081.36-879.44 -3.15%
S&P 5003,128.21-97.68 -3.03%
NASDAQ8,965.61-255.67 -2.77%

JP Morgan Upgrades Arena Pharmaceuticals to Overweight, Announces $58 Price Target

JP Morgan analyst Jessica Fye upgrades Arena Pharmaceuticals (NASDAQ:ARNA) from Neutral to Overweight and announces $58 price target.

Benzinga · 01/31/2020 11:15

JP Morgan analyst Jessica Fye upgrades Arena Pharmaceuticals (NASDAQ:ARNA) from Neutral to Overweight and announces $58 price target.